Financial Impact of Intraviteal Ranibizumab or Aflibercepte for Neovascular Age-Related Macular Degeneration and for Macular Edema Secondary to Central Retinal Vein Occlusion Coverage for a Health Care System of Public Employees Located in ...
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1278
https://www.valueinhealthjournal.com/article/S1098-3015(16)32644-4/fulltext
Title :
Financial Impact of Intraviteal Ranibizumab or Aflibercepte for Neovascular Age-Related Macular Degeneration and for Macular Edema Secondary to Central Retinal Vein Occlusion Coverage for a Health Care System of Public Employees Located in ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32644-4&doi=10.1016/j.jval.2016.09.1278
First page :
A567
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1198